168 related articles for article (PubMed ID: 18196919)
1. Genetic testing for familial cancer. The French National Report (year 2003).
Eisinger F
Community Genet; 2008; 11(1):63-7. PubMed ID: 18196919
[TBL] [Abstract][Full Text] [Related]
2. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
[TBL] [Abstract][Full Text] [Related]
3. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.
Maheu C; Thorne S
Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940
[TBL] [Abstract][Full Text] [Related]
4. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
5. [Psychosocial factors associated with genetic testing for certain hereditary types of neoplasms].
Franková V; Zidovská J; Krutílková V; Havlovicová M; Goetz P
Cas Lek Cesk; 2003; 142(10):599-602. PubMed ID: 14635423
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of genetic testing for inherited breast and ovarian cancer risk.
Calzone KA
Nurs Spectr (Wash D C); 1998 Nov; 8(23):12-4. PubMed ID: 10542772
[No Abstract] [Full Text] [Related]
7. [The supply of breast/ovarian cancer genetic susceptibility tests in France].
Sevilla C; Bourret P; Noguès C; Moatti JP; Sobol H; Julian-Reynier C;
Med Sci (Paris); 2004; 20(8-9):788-92. PubMed ID: 15361346
[TBL] [Abstract][Full Text] [Related]
8. Professional challenges in cancer genetic testing: who is the patient?
Chan-Smutko G; Patel D; Shannon KM; Ryan PD
Oncologist; 2008 Mar; 13(3):232-8. PubMed ID: 18378533
[TBL] [Abstract][Full Text] [Related]
9. DNA diagnosis and the emergence of cancer genetic services in European health care.
Stemerding D; Koch L; Bourret P
Eur J Hum Genet; 1997; 5 Suppl 2():25-30. PubMed ID: 9450191
[No Abstract] [Full Text] [Related]
10. Genetic services for hereditary breast/ovarian and colorectal cancers - physicians' awareness, use and satisfaction.
Carroll JC; Cappelli M; Miller F; Wilson BJ; Grunfeld E; Peeters C; Hunter AG; Gilpin C; Prakash P
Community Genet; 2008; 11(1):43-51. PubMed ID: 18196917
[TBL] [Abstract][Full Text] [Related]
11. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
[TBL] [Abstract][Full Text] [Related]
12. Hereditary breast cancer: from bench to bedside.
De Grève J; Sermijn E; De Brakeleer S; Ren Z; Teugels E
Curr Opin Oncol; 2008 Nov; 20(6):605-13. PubMed ID: 18841041
[TBL] [Abstract][Full Text] [Related]
13. [Information spreading about hereditary carriage of a BRCA1/2 mutation and ovarian cancer and rate of consultation of the concerned relatives].
Christophe V; Leroy T; Adenis C; Reich M; Vennin P
Bull Cancer; 2008 Apr; 95(4):395-402. PubMed ID: 18495568
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
15. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
16. Cancer genetic testing and assisted reproduction.
Offit K; Kohut K; Clagett B; Wadsworth EA; Lafaro KJ; Cummings S; White M; Sagi M; Bernstein D; Davis JG
J Clin Oncol; 2006 Oct; 24(29):4775-82. PubMed ID: 16840542
[TBL] [Abstract][Full Text] [Related]
17. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
James PA; Harris M; Lindeman GJ; Mitchell G
J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
[No Abstract] [Full Text] [Related]
18. Preimplantation genetic diagnosis for cancer predisposition syndromes.
Spits C; De Rycke M; Van Ranst N; Verpoest W; Lissens W; Van Steirteghem A; Liebaers I; Sermon K
Prenat Diagn; 2007 May; 27(5):447-56. PubMed ID: 17330926
[TBL] [Abstract][Full Text] [Related]
19. Introduction to molecular and clinical genetics of colorectal cancer syndromes.
Tops CM; Wijnen JT; Hes FJ
Best Pract Res Clin Gastroenterol; 2009; 23(2):127-46. PubMed ID: 19414141
[TBL] [Abstract][Full Text] [Related]
20. A BRCA2 mutation, 4088insA, in a Finnish breast and ovarian cancer family associated with favourable clinical course.
Hartikainen JM; Mannermaa A; Heinonen S; Kosma VM; Kataja V
Anticancer Res; 2007; 27(6C):4295-300. PubMed ID: 18214034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
